Cutler Group’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$15K Sell
200
-400
-67% -$33.6K 0.01% 1106
2023
Q4
$47K Sell
600
-200
-25% -$13.4K 0.01% 1478
2023
Q3
$55K Buy
+800
New +$59.8K 0.01% 1449
2023
Q2
Sell
-2,156
Closed -$159K 3578
2023
Q1
$132K Sell
2,156
-3,170
-60% -$208K 0.02% 862
2022
Q4
$410K Sell
5,326
-7,039
-57% -$421K 0.05% 510
2022
Q3
$551K Buy
12,365
+8,995
+267% +$449K 0.07% 485
2022
Q2
$129K Sell
3,370
-4,450
-57% -$141K 0.02% 1271
2022
Q1
$323K Sell
7,820
-12,610
-62% -$391K 0.03% 898
2021
Q4
$771K Buy
20,430
+3,076
+18% +$113K 0.05% 556
2021
Q3
$571K Buy
17,354
+12,804
+281% +$499K 0.04% 722
2021
Q2
$306K Buy
4,550
+775
+21% +$46.5K 0.02% 1041
2021
Q1
$213K Sell
3,775
-2,912
-44% -$205K 0.02% 1225
2020
Q4
$544K Buy
6,687
+5,187
+346% +$388K 0.04% 594
2020
Q3
$106K Sell
1,500
-2,170
-59% -$169K 0.01% 1280
2020
Q2
$301K Buy
3,670
+1,270
+53% +$97.7K 0.03% 664
2020
Q1
$141K Sell
2,400
-1,050
-30% -$85.6K 0.01% 1150
2019
Q4
$356K Sell
3,450
-7,120
-67% -$288K 0.03% 570
2019
Q3
$213K Buy
10,570
+2,520
+31% +$64.8K 0.03% 675
2019
Q2
$207K Sell
8,050
-5,250
-39% -$105K 0.02% 697
2019
Q1
$189K Buy
+13,300
New +$123K 0.02% 672

Other funds holding AXSM